About Sigma Global

Sigma Global Corporation provides direct-to-consumer medical products and services, including integrated programs that help improve the process of long-term health maintenance for seniors and those suffering from chronic disease. The company operates a fully licensed pharmacy and distribution center that serves healthcare facilities, physicians and patients throughout North America and Puerto Rico. The company provides prescription medications, services and pharmaceutical solutions for the management of chronic conditions in senior patients. It also provides nebulizer technology and diabetic products and supplies to help its patients feel better, live longer, and improve and improve quality of life. The company provides generic medications, respiratory and diabetic supplies. Products The company’s products include Ailments for Bacterial Infections Bone & Joint, Depression, Dermatological, Diabetes, Digestive, Epilepsy, Glaucoma, Gout, Heart Disease, Herpes, Hypertension, Hyperthyroidism, Lou Gehrig's Disease, Malaria, Muscular, Nausea, Pain Management, Parkinson's Disease, Psychological, Reproductive; Equipment for Diabetes Testing, Respiratory; Plans for Diabetes; Prescriptions for Anesthetics, Contraceptives, Generic, and Respiratory. Joint Venture In October 2005, the company has launched Biometis, a medical device and pharmaceutical joint venture with Stason Pharmaceuticals, Inc. Biometis is a Texas corporation with operations in both California and Texas. Biometis intends to introduce its own line of medical devices and generic pharmaceuticals targeted at patients with chronic diseases to retailers, institutions and consumer-direct outlets nationwide. Biometis, the company’s joint venture with Stason Pharmaceuticals, manufactures and distributes medical devices and generic pharmaceuticals to physicians, healthcare institutions, retailers and consumer-direct providers.